Mechanisms and Clinical Practice of Integrated Traditional and Western Medicine Treatment for Brain Gliomas
DOI:
https://doi.org/10.61173/yjj0e261Keywords:
Glioma, Integrated Traditional Chinese and Western Medicine, Toxicity Reduction, Tumor Microen-vironment, Molecular MechanismsAbstract
Glioma is the most common malignant tumor in the central nervous system, which is difficult to treat and prone to recurrence. In recent years, traditional Chinese medicine (TCM) has shown unique advantages in reducing the toxicity of radiotherapy and chemotherapy and improving the quality of life of patients. However, the specific mechanism and systematic integration of integrated traditional Chinese and Western medicine (TCM and WM) treatment still need to be further explored. This article systematically reviews the progress of basic and clinical research on the treatment of glioma with TCM. The results show that some active components of TCM can inhibit the progression of glioma through mechanisms such as inducing tumor cell apoptosis and inhibiting DNA repair. Clinical observations indicate that the combination of TCM and WM can effectively alleviate bone marrow suppression caused by temozolomide chemotherapy, improve patients‘ cognitive function, and to some extent, prolong survival. This study provides theoretical support and practical basis for the integrated TCM and WM treatment of glioma. In the future, large-scale clinical research should be further carried out, the mechanism of action of TCM should be deeply explored, and the standardized and individualized application of integrated TCM and WM treatment should be promoted.
References
[1] Medical Administration Bureau of the National Health Commission, Tao L. Diagnosis and treatment guidelines for glioma (2018 edition). Chinese Journal of Neurosurgery, 2019, 35(3): 217-239.
[2] Price M, Ballard C, Benedetti J, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2017-2021. Neuro-Oncology, 2024, 26(Supplement 6): vvi1-vi85.
[3] Louis D N, Perry A, Wesseling P, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro-Oncology, 2021, 23(8): 1231-1251.
[4] Stupp R, Hege M E, Mason W P, et al. Impact of concurrent and adjuvant temozolomide with radiotherapy versus radiotherapy alone on survival in glioblastoma: 5-year analysis of the EORTC-NCIC trial. Annals of Oncology, 2009, 10(5): 459-466.
[5] Zhang W, Wang Z. Guidelines for the integrated diagnosis and treatment of glioma in China: a concise version (2022). Chinese Journal of Clinical Oncology, 2022, 49(16): 811-818.
[6] Chen W L, Wang Y K, Liu Q S, et al. Research advances in glioma in China: annual review of 2022. Medical Journal of Peking Union Medical College Hospital, 2023, 14(5): 983-990.
[7] Ater J L, Zhou T, Holmes E, et al. Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children: a report from the Children’s Oncology Group. Journal of Clinical Oncology, 2012, 30(21): 2641-2647. Dean&Francis ISSN 2959-409X
[8] Cao J R, Zhang J L, Zhang Y Y, et al. Research progress on treatment methods for glioma. Medical Frontier, 2025, 15(1): 43-48.
[9] Neurosurgery Professional Committee of Shanghai Association of Chinese Integrative Medicine, Writing Group of Expert Consensus on Integrated Traditional Chinese and Western Medicine Clinical Diagnosis and Treatment of Brain Glioma (Shanghai). Expert consensus on integrated traditional Chinese and Western medicine clinical diagnosis and treatment of brain glioma (Shanghai). Journal of Shanghai University of Traditional Chinese Medicine, 2023, 37(5): 1-10.
[10] Yang X J, Shi W, Zhang K. Development and innovation in the diagnosis and treatment of glioma in China: 2024 review. Chinese Journal of Contemporary Neurology and Neurosurgery, 2025, 25(3): 161-164.
[11] Cheng M Q, Qin Y G, Jiang J L, et al. Clinical research progress on traditional Chinese medicine for the treatment of glioma. Journal of Liaoning University of Traditional Chinese Medicine, 2020, 22(12): 147-151.
[12] Chen Z Y, Zhao X P, Fan X X, et al. Research progress on the mechanism of traditional Chinese medicine in the treatment of glioma. Global Traditional Chinese Medicine, 2024, 17(5): 959-964.
[13] Qi F, Zhao X P, Fan X X, et al. Research progress on traditional Chinese medicine regulating tumor microenvironment for treatment of glioma. Chinese Journal of Experimental Traditional Medical Formulae, 2024, 30(16): 303-314.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 by the authors.

This work is licensed under a Creative Commons Attribution 4.0 International License.
